Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA): Buffett News

TEVA – Berkshire Hathaway more than doubled its stake in Teva to 40.5M shares.


Key Facts Surrounding This News Item


  • TEVA had a POWR Rating of C (Neutral) coming into today.
  • TEVA was 8.00% above its 10-Day Moving Average coming into today.
  • TEVA was 11.32% above its 20-Day Moving Average coming into today.
  • TEVA was 12.81% above its 50-Day Moving Average coming into today.
  • TEVA was 7.37% above its 100-Day Moving Average coming into today.
  • TEVA was 15.61% above its 200-Day Moving Average coming into today.
  • TEVA had returned +7.55% year-to-date leading up to today’s news, versus a +2.70% return from the benchmark S&P 500 during the same period.

More Info About Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)


Teva Pharmaceuticals manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines. The company was founded in 1901 and is based in Petach Tikva, Israel. View our full TEVA ticker page with ratings, news, and more.

TEVA at a Glance

TEVA Current POWR Rating™
Overall POWR Rating™
TEVA Current Price $22.62 0.22%
More TEVA Ratings, Data, and News

TEVA Price Reaction

The day of this event (May. 15, 2018)
TEVA Closing Price$20.30 0.39%
TEVA Volume9,426,900
48.99% from avg
Leading up to this event
TEVA 1-mo returnN/A%
After this event
TEVA 1-day return2.39%
TEVA 3-day return4.00%
TEVA 5-day return2.95%

TEVA Price Chart



More Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All TEVA News
Page generated in 1.0415 seconds.